Design and screening of novel endosomal escape compounds that enhance functional delivery of oligonucleotides in vitro
Antisense oligonucleotides (ASOs), including splice-switching oligonucleotides (SSOs), are promising therapeutic approaches for targeting genetic defects. ASOs act in the nucleus and the cytosol to cleave mRNAs via the RNaseH1 mechanism (e.g., gapmers), while SSOs alter transcript splicing to restor...
保存先:
| 主要な著者: | , , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2025-06-01
|
| シリーズ: | Molecular Therapy: Nucleic Acids |
| 主題: | |
| オンライン・アクセス: | http://www.sciencedirect.com/science/article/pii/S2162253125000769 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
